Neurotech International Ltd (NTI) - Total Liabilities

Latest as of June 2026: AU$2.14 Million AUD ≈ $1.51 Million USD

Based on the latest financial reports, Neurotech International Ltd (NTI) has total liabilities worth AU$2.14 Million AUD (≈ $1.51 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NTI financial resilience to evaluate the company's liquid asset resilience ratio.

Neurotech International Ltd - Total Liabilities Trend (2015–2026)

This chart illustrates how Neurotech International Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Neurotech International Ltd asset portfolio.

Neurotech International Ltd Competitors by Total Liabilities

The table below lists competitors of Neurotech International Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Zenta Group Company Limited Ordinary Shares NASDAQ:ZGM	USA	$429.97K
Enero Group Ltd AU:EGG	Australia	AU$70.05 Million
Kwang Jin Ind. Co. Ltd KQ:026910	Korea	₩78.45 Billion
Arandu Investimentos S.A. SA:ARND3	Brazil	R$158.95 Million
Kresna Graha Investama Tbk PT JK:KREN	Indonesia	Rp819.00 Billion
Indian Terrain Fashions Limited NSE:INDTERRAIN	India	Rs2.55 Billion
Moatech Co. Ltd KQ:033200	Korea	₩7.37 Billion
Citius Pharmaceuticals Inc NASDAQ:CTXR	USA	$63.46 Million

Liability Composition Analysis (2015–2026)

This chart breaks down Neurotech International Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Neurotech International Ltd (NTI) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.29	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.78	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neurotech International Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neurotech International Ltd (2015–2026)

The table below shows the annual total liabilities of Neurotech International Ltd from 2015 to 2026.

Year	Total Liabilities	Change
2026-06-30	AU$2.14 Million ≈ $1.51 Million	+647.62%
2025-06-30	AU$285.74K ≈ $202.18K	-9.20%
2024-06-30	AU$314.70K ≈ $222.67K	-76.63%
2023-06-30	AU$1.35 Million ≈ $952.99K	+127.14%
2022-06-30	AU$592.98K ≈ $419.57K	-48.19%
2021-06-30	AU$1.14 Million ≈ $809.75K	+57.40%
2020-06-30	AU$727.10K ≈ $514.47K	+104.62%
2019-06-30	AU$355.33K ≈ $251.42K	-5.41%
2018-06-30	AU$375.66K ≈ $265.80K	-42.83%
2017-06-30	AU$657.04K ≈ $464.90K	-26.43%
2016-06-30	AU$893.12K ≈ $631.94K	-55.08%
2015-12-31	AU$1.99 Million ≈ $1.41 Million	--

About Neurotech International Ltd

AU:NTI Australia Biotechnology

Market Cap

$16.01 Million

AU$22.62 Million AUD

Market Cap Rank

#25891 Global

#1143 in Australia

Share Price

AU$0.01

Change (1 day)

+7.69%

52-Week Range

AU$0.01 - AU$0.02

All Time High

AU$0.48